MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Strategic Minerals posts quarterly sales growth

ALN

The following stocks are the leading risers and fallers on AIM on Thursday.

----------

AIM - WINNERS

----------

Strategic Minerals PLC, up 6.7% at 0.42 pence, 12-month range 0.0025p-0.50p. Reports first-quarter sales revenue of $1.2 million, up 41% on-year from $840,000 as sales volumes rise 38% to 17,162 tonnes from 12,393 tonnes. Also reports a cash balance of $530,000 at March 31 against $250,000 a year before, due to ‘strong’ quarterly sales volumes at the Cobre magnetite operation in the US state of New Mexico. ‘The company continued to post strong operational and financial results in the first quarter of 2025 which will support the renewed focus on critical minerals exploration and development at the Redmoor tungsten-tin-copper project in Cornwall,’ says Executive Director Mark Burnett.

----------

Cambridge Cognition Holdings PLC, up 4.2% at 38.00 pence, 12-month range 26.40p-54.98p. Wins a new contract worth around £1.2 million with an unnamed ‘major’ pharmaceutical firm for the provision of digital cognitive and voice assessments for two phase 3 clinical trials in adolescents with major depressive disorder. Both trials are set to begin this year, with the first to run until 2027 and the second through to 2029. ‘This strategically important contract win highlights the value of our integrated speech and cognitive platform that not only delivers robust and reliable results for the pharmaceutical company but also reduces trial costs and patient burden. As a result, we see significant future demand for our unique platform, and we remain confident in our ambitions to significantly grow sales in the high-impact, late-stage CNS trials market over the coming years,’ says Chief Operating Officer & Joint Managing Director Rob Baker.

----------

AIM - LOSERS

----------

Oracle Power PLC, down 6.7% at 0.020p, 12-month range 0.012p-0.075p. Says assay results to date at the Northern Zone intrusive hosted gold project in Western Australia continue to confirm the presence of high grade gold intercepts within a lower grade gold halo. Chief Executive Officer Naheed Memon says: ‘These latest results complement the previous results, and those released since late 2023, as we increase the footprint of the gold mineralisation. The results continue to meet or exceed our expectations, revealing good tenor within the shallower oxide gold mineralisation at the top of the mineralised porphyry. We have a total of 1,756 samples in the lab awaiting assay from 36 drill holes to be reported in due as we continue to advance the Northern Zone project.’

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.